|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 385.00 JPY | -2.04% |
|
-18.26% | - |
| 05-13 | Innovacell Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| 05-13 | Innovacell Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2026 | CI |
| Market Cap | 17.72B 110M 96.31M 88.74M 82.97M 156M 10.35B 158M 1.06B 412M 5.1B 412M 403M | P/E 2026 * |
-4.82x | P/E 2027 * | -4.55x |
|---|---|---|---|---|---|
| Enterprise Value | 17.72B 110M 96.31M 88.74M 82.97M 156M 10.35B 158M 1.06B 412M 5.1B 412M 403M | EV / Sales 2026 * |
17.7x | EV / Sales 2027 * | 16.4x |
| Free-Float |
52.14% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.04% | ||
| 1 week | -18.26% | ||
| Current month | -31.98% | ||
| 1 month | -40.77% | ||
| 3 months | -54.17% |
| 1 week | 377 |  | 474 |
| 1 month | 377 | | 710 |
| Current year | 377 | | 1,248 |
| 1 year | 377 | | 1,248 |
| 3 years | 377 | | 1,248 |
| 5 years | 377 | | 1,248 |
| 10 years | 377 | | 1,248 |
| Manager | Title | Age | Since |
|---|---|---|---|
Colin Lee Novick
CEO | Chief Executive Officer | 45 | 2022-02-28 |
Jason Sieger
CEO | Chief Executive Officer | 43 | 2025-02-28 |
Yasushi Hosono
DFI | Director of Finance/CFO | 59 | 2021-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Jason Sieger
BRD | Director/Board Member | 43 | 2020-12-31 |
Colin Lee Novick
BRD | Director/Board Member | 45 | 2021-06-30 |
| Director/Board Member | 56 | 2021-03-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.04% | -18.26% | - | - | 110M | |
| +0.93% | +2.65% | +42.33% | +145.77% | 1,006B | |
| +1.61% | +7.22% | +60.81% | +47.98% | 589B | |
| +3.51% | +12.31% | +31.15% | +78.88% | 430B | |
| -1.28% | +5.11% | +29.26% | +21.27% | 331B | |
| -0.70% | +5.53% | +37.67% | +23.68% | 288B | |
| -1.58% | +5.09% | +29.47% | +39.81% | 285B | |
| -2.68% | +5.00% | -28.62% | -42.77% | 213B | |
| +0.40% | +4.51% | +25.85% | +55.35% | 190B | |
| -1.05% | +0.06% | +16.91% | +59.86% | 154B | |
| Average | -0.56% | +3.43% | +27.20% | +47.76% | 348.59B | |
| Weighted average by Cap. | -0.20% | +5.38% | +35.04% | +70.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1B 6.19M 5.43M 5.01M 4.68M 8.78M 584M 8.94M 60.07M 23.27M 288M 23.23M 22.72M | 1.08B 6.67M 5.86M 5.4M 5.05M 9.46M 629M 9.64M 64.76M 25.08M 310M 25.04M 24.49M |
| Net income | -3.46B -21.42M -18.82M -17.34M -16.21M -30.41M -2.02B -30.96M -208M -80.58M -996M -80.45M -78.69M | -3.81B -23.56M -20.69M -19.07M -17.83M -33.43M -2.22B -34.05M -229M -88.6M -1.1B -88.47M -86.53M |
| Net Debt | - | - |
Employees
48
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-26 | JP¥385.00 | -2.04% | 136,600 |
| 26-06-25 | JP¥393.00 | -5.76% | 269,400 |
| 26-06-24 | JP¥417.00 | -6.50% | 148,400 |
| 26-06-23 | JP¥446.00 | +0.22% | 119,600 |
| 26-06-22 | JP¥445.00 | -5.52% | 116,300 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 504A Stock
Select your edition
All financial news and data tailored to specific country editions
